Background: Irritable bowel and sensitive skin syndromes are common painful
understood. This concept has been challenged and is based on measurements of subjective pain thresholds evoked by experimental visceral stimuli (Camilleri, 2002) as well as objective data demonstrating hyperexcitability of pain systems in IBS patients (Coffin, Bouhassira, Sabaté, Barbe, & Jian, 2004) . Epidemiological studies demonstrated that IBS is frequently associated with several comorbidities, both intestinal and extraintestinal, especially in the context of chronic overlapping pain conditions (Maixner, Fillingim, Williams, Smith, & Slade, 2016) . Nonetheless, an association with sensitive skin syndromes has not been reported to date (Jones, Latinovic, Charlton, & Gullifor, 2006; Riedl et al., 2008) .
Sensitive skin syndrome (SSS) is a frequent complaint in the general population and is defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus and tingling sensations) in response to stimuli that normally should not provoke such sensations . These unpleasant sensations cannot be explained by lesions attributable to any other skin disease. The skin can appear normal or be accompanied by erythema. Sensitive skin can affect all body locations, especially the face. Because SSS is mainly characterized by a wide variety of sensory symptoms, it is highly likely that a neurosensory dysfunction in the skin represents one of the main pathological mechanisms of sensitive skin (Stander, Schneider, Weishaupt, Luger, & Misery, 2009) . A systematic study that tested these pathophysiological hypotheses only found evidence for the neuronal hypothesis (Buhé et al., 2016) , showing that the intraepidermal nerve fibre density was significantly reduced. Similarly, to IBS, SSS occurs secondary to skin hyperexcitability and/or a lowering of perception thresholds (Misery, 2017) .
Hence, IBS and SSS are both characterized by the occurrence of pain and functional symptoms that are triggered by various stimuli, which can be chemical and/or physical. These syndromes are related to alterations of the peripheral nervous system, especially the nerve endings but are also likely related to central sensitivity to pain (Yunus, 2015) . Consequently, these syndromes could be associated in many cases, but there are no epidemiological studies confirming this hypothesis. Thus, we performed a large epidemiological survey to search for an association between IBS and SSS.
| METHODS
A survey was conducted in France on a representative sample of the general population aged 15-79 years, which was recruited using the stratified random sampling method. Based on a database with the email addresses of 900,000 Internet users who agreed to participate in surveys, fixed quotas of subjects fulfilling predefined socio-demographic criteria were recruited. Drawing on national population data, these quotas were based on the following aspects: sex, age (six categories), socio-professional status (three categories) and regional distribution (nine regions), thereby ensuring an accurate representation of the French sample population. The target size for the entire sample was 5,000 people.
A group of experts in IBS or SSS developed a questionnaire. The questionnaire was designed to be understood by most people in the general population. Socio-demographic characteristics were collected, in addition to data regarding SSS or IBS. The interviewed people were asked to answer questions regarding IBS according to the Rome III criteria (Longstreth et al., 2006) . The respondents also answered a general question about the presence of sensitive skin and specific questions about the triggering of pain, burnings, tingling or skin irritation by emotions, cold, heat, sun exposure, cosmetics, water, dry air, air conditioning, pollution, variations of temperature or the absence of any obvious reason. The quality of life was evaluated thanks to the SF12 questionnaire (Ware, Kosinski, & Keller, 1996) and the short version of the SF-36, which is a generic instrument used to measure population health. A physical composite score and a mental composite score can be calculated based on the 12 questions, although there is no global SF12 score.
Quantitative variables were expressed as the mean and standard deviation. Qualitative variables were expressed as frequencies and percentages. Comparisons between groups were performed using the Student t test in the case of two groups of quantitative variables. ANOVA was used if there were more than two groups. If the use of these tests was not pertinent, nonparametric tests (Wilcoxon or KruskalWallis) were performed. For qualitative variables, intergroup comparisons were done with the chi-square test or Fischer's test, if necessary. The level of significance was set at 5%. Data were analysed using SAS ® software version 8.2 (SAS Institute Inc., Cary, USA) on Windows hardware. Each variable was evaluated independently in a univariate analysis adjusted for age, sex and SSS or IBS to identify factors associated with SSS or IBS. Variables were retained in a stepwise manner in order to determine the variables that were independently associated with SSS or IBS at a probability threshold of 0.05. Odds ratios (ORs) were consequently generated.
| RESULTS
The distribution of the sample was done with respect to quotas based on sex, age, socio-professional status and regional distribution in the French sample population.
Among 5,000 interviewed persons, 2,443 were men (48.9%), and 2,557 (51.1%) were women. According to the Rome III criteria, 14.6% presented with IBS and was more frequently found in women than men (17.5% vs. 11.6%, p < 0.001). In other words, 61.2% were women. The answers to the questionnaire are given in Table 1 .
Among the general population, 59.1% declared very sensitive or fairly sensitive skin (together: sensitive skin), with a greater frequency of women (66.0%) versus men (51.9%) (p < 0.001). A total of 16.5% of women and 10.4% of men reported very sensitive skin (p < 0.001). Consequently, 40.9% did not declare sensitive skin (33.2% slightly sensitive and 7.7% not sensitive).
Interestingly, 73.1% of people with IBS declared SSS versus 52.3% of people without IBS (p < 0.001). Table 2 shows that very sensitive skin is very frequently associated with IBS (p < 0.001). Moreover, the frequency of IBS was higher according to the severity of SSS, as shown in Figure 1 (p < 0.001) .
Regarding the quality of life as assessed by SF12, Table 3 shows that it was altered in both mental and physical dimensions in patients with IBS (p < 0.001) as well as those with SSS (p < 0.001) and was enhanced when the two conditions were associated with a gradient according to the severity of sensitive skin.
The presence of SSS (defined as fairly or very sensitive skin) was highly associated with the presence of abdominal pain or discomfort (OR 2.06 [95% CI 1.72-2.47], p < 0.0001). After adjustment for sex and age, SSS SF12-P is the score for the physical dimension, and SF12-M is for the mental condition 
| DISCUSSION
This study is the first to demonstrate that there is an association between IBS and SSS, which are two painful and frequent conditions found especially in women. SSS is more frequent in people with IBS. Reciprocally, IBS is more frequent in people with SSS and associated with severity. The quality of life is altered in both conditions and is altered to a greater degree if they are associated. Although the diagnosis was not confirmed by a medical doctor, the subjectivity of symptoms allows performance of trustworthy studies using surveys, while this kind of study is frequently performed for IBS (Mujagic et al., 2015) and SSS . Recently, new criteria were defined to identify IBS (Rome IV) (Mearin et al., 2016) . The term discomfort was removed from IBS criteria, as studies found that it was defined differently across care settings, ranging from a mild form of bloating or a collection of symptoms to urgency. Now, the term pain is used to establish a diagnosis of IBS. Additionally, the threshold for pain increased from 3 days per month to 1 day per week based on normative bowel symptom data in the US population (Chang, 2017) . This threshold does not call into question our results, which are similar to previous results stating a prevalence of IBS in France of approximately 15% (Dapoigny, 2009) , in addition to a higher prevalence in females and a mean age close to that reported by previous studies. In the same manner, the prevalence of SSS in France was identical to previously shown rates (Misery, Boussetta, Nocera, Perez-Cullell, & Taieb, 2009) .
The following four studies showed that there is an increase in the cutaneous sensitivity to pain in experimental conditions. Our study supports this hypothesis. Increased visceral and somatic pain sensitivity among adults reporting IBS symptoms has been previously shown in a large population-based study (Stabell, Stubhaug, Flaegstad, & Nielsen, 2013) . Concerning somatic pain, compared with control subjects, IBS patients had reduced cold-pressor tolerance, increased cold-pressor pain intensity ratings and lower heat-pain thresholds, after adjusting for sex and age. These results remained significant when controlling for comorbid chronic pain and psychological distress. The results for pressure-pain threshold were not significant. Heat-and cold-pressor pain sensitivities were greatest for the IBS patients reporting severe chronic abdominal pain, indicating that hyperalgesia in IBS is related to the degree of clinical pain rather than the diagnosis, per se. This study was performed on upper extremities, but a previous smaller study rated pain intensity and unpleasantness to distension of the rectum and thermal stimulation of the hand and foot (Verne, Obinson, & Price, 2001) . Patients with IBS demonstrated cutaneous allodynia/hyperalgesia to thermal pain. The cutaneous hyperalgesia was pronounced in the lower extremity, yet presented in the upper extremity to a lesser extent. In another work, pain sensitivity was probed with cutaneous thermal stimulation to the lower and upper extremities and the face in diarrhoea-predominant IBS patients and healthy female controls (Rodrigues, Verne, Schmidt, & Mauderli, 2005) . The stimuli were administered with a contact thermode, assuring that the size of the stimulated area and stimulus duration were clearly defined and identical in all locations. Sensitization of IBS patients was not limited to symptomatic dermatomes (calf) but extended evenly across the body, including the face (no sensitization gradient from foot to face). Additionally, the difference between IBS patients and control groups did not depend on the evoked pain intensity level, that is, the degree of sensitization of IBS patients was similarly near threshold (10% on the visual analog scale) and at higher intensities. Further studies with measurements of IBS severity using the Francis score and Bristol scale are needed. Finally, another study (Liu et al., 2014) also found significant correlations between visceral and somatic hypersensitivities, visceral hypersensitivity and autonomic cardiovascular dysfunction, and somatic hypersensitivity and autonomic cardiovascular dysfunction in patients with IBS.
Furthermore, it would be of interest to note that an animal model of colonic hypersensitivity also evokes changes in cutaneous mechanical hypersensitivity. Thus, butyrate enemas induce a sustained colonic hypersensitivity and referred cutaneous mechanical hyperalgesia, particularly in female rats (Bourdu et al., 2005) . In this interesting study, pain was inhibited by a CGRP antagonist, that could make sense for SSS because there is an important increase in CGRP immunoreactive-nerve ending density in the skin in patients with sensitive skin (Buhé et al., 2016) .
A brain imaging analysis revealed that both rectal distension and cutaneous heat stimuli evoked greater neural activity in several brain regions of IBS patients in comparison with age/sex-matched control subjects (Verne et al., 2003) . These regions include those related to early stages of somatosensory processing (e.g., thalamus, somatosensory cortex), as well as those more related to cognitive and affective processing (insular, anterior cingulate, posterior cingulate, prefrontal cortex). These results support the hypothesis that hyperalgesia of IBS (but also cutaneous heat hyperalgesia) is manifested by increased somatosensory processing at all cortical levels. Furthermore, visceral hyperalgesia and heat hyperalgesia were accompanied by increased neural activity within the same brain structures. These results support the hypothesis that visceral hyperalgesia and cutaneous hyperalgesia in IBS patients are related to increased afferent processing in pathways ascending to the brain rather than to selectively increased activity at higher cortical levels (e.g., limbic and frontal cortical areas).
Another brain imaging study showed that skin discomfort due to lactic acid increased activity in the primary sensorimotor cortex contralateral to the application site and in the bilateral fronto-parietal network, including the parietal cortex, prefrontal areas around the superior frontal sulcus and the supplementary motor area in patients with SSS and healthy controls (Querleux et al., 2008) . However, activity was significantly larger in the sensitive skin group. Most remarkably, in the sensitive skin group only, activity spread into the ipsilateral primary sensorimotor cortex and the bilateral peri-insular secondary somatosensory area. These results suggest that SSS subjects have a specific cerebral activation during skin irritation tests, allowing us to hypothesize that self-perceived sensitive skin is intrinsically linked to a specific neurophysiologic pattern for these subjects.
Consequently, IBS and SSS share common mechanisms of central sensitivity, which may be defined as a state of hyperexcitement of the central nervous system involving the spinal and supraspinal structures due to an amplification of neural signalling involving various synaptic and neurotransmitter activities irrespective of a defined peripheral input (Yunus, 2015) . Central sensitivity syndromes (CSS) are defined by the presence of central sensitization, in association with another member of the CSS family that is based on a study with a matched control group or wellestablished age-and gender-matched population control and the absence of an underlying disease that may cause CS (Yunus, 2015) . Until now, SSS was not included in CSS (Yunus, 2015) , but our study clearly shows that SSS may be included in the list. It could open very new therapeutic options. As an example, multisensory integration has been suggested experimentally using "out of body" illusions which decreased pain in IBS and other chronic conditions, suggesting high-level multisensory body representations (Pamment & Aspell, 2017) . Another point is that visceral pain has been shown to be a triggering factor for fibromyalgia (another CSS) in comorbid patients with IBS (Costantini, Affaitati, Wesselmann, Czakanski, & Giamberardino, 2017 ) and it could be also possible in patients with SSS.
Central sensitization is usually associated with peripheral sensitization (Kuner, 2010) , with activation of A-delta and C nociceptive fibres by various factors, which is accompanied by a barrage of impulses that activate the postsynaptic receptors, resulting in escalation of the hyperexcitability of the secondary neurons with marked amplification of the peripheral stimulus.
Recent advances in molecular neurophysiology provide knowledge to better understand the underlying mechanism in pain generation in IBS patients. Sensitization of peripheral nociceptive afferents, more specifically high-threshold afferents, has been proposed as one of the principle mechanisms in the development of visceral hypersensitivity (Boeckxstaens & Wouters, 2017) . In addition to direct neuronal activation, low concentrations of proteases, histamine and serotonin can chronically sensitize nociceptors, such as TRP channels, leading to persistent aberrant pain perception (Keszthelyi et al., 2012) . IBS patients with visceral hypersensitivity to rectal distension reveal increased pain perception to rectal application of capsaicin (van Wanrooij et al., 2014) . TRPV1 hyperactivation is also one of the most widely known mechanisms of SSS (Misery, Loser, & Ständer, 2016) . Neurogenic inflammation is strongly involved in the pathogenesis of both IBS (Feng, La, Schwartz, & Gebhart, 2012) and SSS (Stander et al., 2009) . In SSS, a neuropathic component of pain has been evidenced (Saint-Martory et al., 2015) , and there are arguments in favour of a small-fibre neuropathy (Buhé et al., 2016 ) that could also be involved in IBS.
Fibromyalgia, another painful condition, can be also associated with IBS but SSS has not been reported as a comorbidity of fibromyalgia until now (Fitzcharles, Perrot, & Häuser, 2018) . Patients with IBS and fibromyalgia were more bothered by the somatic stimuli and had somatic hyperalgesia with lower pain thresholds and higher pain frequency and severity (Chang, Mayer, Johnson, FitzGerald, & Naliboff, 2000) . Some paraesthesias can be present in patients with fibromyalgia but there is never allodynia in response to pressure (a key symptom of fibromyalgia) in patients with sensitive skin. Sensitive skin is an epidermal disorder (Buhé et al., 2016) while fibromyalgia is subcutaneous. The pain thresholds were normal in skin, and lower than normal in subcutis and muscle in IBS, while patients with fibromyalgia (associated with IBS or not) demonstrated somatic hypersensitivity at all sites, suggesting that multiple mechanisms may modulate perceptual somatic and visceral responses in patients with IBS and FM (Caldarella et al., 2006) . In our study, some patients could have paraesthesia related to fibromyalgia but fibromyalgia is much rarer than sensitive skin (2% vs. 59%) (Clauw, 2014) and these patients would be not many. Consequently, a further study on the association between SSS and fibromyalgia should be highly interesting.
IBS and SSS are clearly associated with alterations of the quality of life. Our study confirms previous results with IBS (Enck, Leinert, Smid, Köhler, & Schwille-Kiuntke, 2016; Lackner, Gudleski, Ma, Dewanwala, & Naliboff, 2014) and SSS (Misery et al., 2007; Saint-Martory et al., 2015) and shows a synergistic effect on the alterations of the quality of life. There are no negligible consequences in practice.
In conclusion, our study provides strong arguments in favour of common mechanisms for IBS and SSS since they are frequently associated with each other and are two painful conditions. These mechanisms could also explain that IBS transit disorders are the equivalent of SSS vasomotor disorders, with putative consequences on research and therapeutics. Moreover, both conditions alter the quality of life with a synergistic effect.
